Oaktree Acquisition Corp. III Life Sciences (OACC) Total Liabilities (2024 - 2026)

Oaktree Acquisition Corp. III Life Sciences filings provide 3 years of Total Liabilities readings, the most recent being $8.6 million for Q1 2026.

  • Quarterly Total Liabilities rose 7.0% to $8.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $8.6 million through Mar 2026, up 7.0% year-over-year, with the annual reading at $8.3 million for FY2025, 7.39% up from the prior year.
  • Total Liabilities hit $8.6 million in Q1 2026 for Oaktree Acquisition Corp. III Life Sciences, up from $8.3 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $8.6 million in Q1 2026 and bottomed at $7.7 million in Q4 2024.
  • Average Total Liabilities over 3 years is $8.2 million, with a median of $8.2 million recorded in 2025.
  • The largest annual shift saw Total Liabilities grew 7.39% in 2025 before it increased 7.0% in 2026.
  • Oaktree Acquisition Corp. III Life Sciences' Total Liabilities stood at $7.7 million in 2024, then rose by 7.39% to $8.3 million in 2025, then increased by 3.9% to $8.6 million in 2026.
  • Per Business Quant, the three most recent readings for OACC's Total Liabilities are $8.6 million (Q1 2026), $8.3 million (Q4 2025), and $8.2 million (Q3 2025).